Alzheimer's Association Global Real-World Data Platforms (ALZ-RWD) Program supports teams developing and using patient data platforms to advance dementia research, care, and health equity.
The inquiry cutoff moves from January 1, 2026 to December 1, 2026. Full applications are now due February 2, 2027 at 5 p.m. ET, replacing the previously listed January 28 and February 2, 2026 deadlines; applications open December 1, 2026, and other details also changed.
Alzheimer’s Association’s HSR-ADRD Funding Program supports researchers studying dementia detection, diagnosis, and care pathways to build evidence for equitable, person-centered care.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Prevention RFP - Alzheimer's Drug Discovery Foundation supports researchers and clinicians conducting human studies of targeted interventions, combination therapies, and drug choices to reduce dementia risk.
Funds research to develop, validate, and translate digital biomarkers (e.g., wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
Alzheimer’s Association Research Grant For All (AARGA) Program supports early-career researchers and clinicians developing pilot data and hypotheses for Alzheimer’s and related dementia research.